A primer probe combination and kit for detecting genotyping related to warfarin medication

A genotyping and kit technology, applied in the biological field, can solve the problems of PCR product cross-contamination, enzyme digestion, primer specificity, and insufficiency, so as to reduce the incidence of medical accidents, improve clinical treatment effects, and reduce drug side effects Effect

Inactive Publication Date: 2019-01-25
CHANGZHOU TCM HOSPITAL
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, this method is complicated to operate, and when the sample size is large, it is easy to cause cross-contamination of PCR products, and it is prone to insufficient or excessive digestion, resulting in false negative or false positive results, and low reliability.
Although the specificity of fluorescent quantitative PCR and multiplex PCR methods has been improved, the principles of these two methods are still based on the principle of ordinary PCR. Factors such as the strength of fluorescent signals, primer specificity, and low-fidelity Taq enzymes can cause impact on results
The DNA sequencing method is relatively expensive and the operation process is cumbersome. In today's rapid development of the human post-genome era, none of these methods can meet the current requirements for rapid and accurate analysis of genetic polymorphisms related to warfarin medication.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A primer probe combination and kit for detecting genotyping related to warfarin medication
  • A primer probe combination and kit for detecting genotyping related to warfarin medication
  • A primer probe combination and kit for detecting genotyping related to warfarin medication

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0019] 1. Fluorescence Quantitative Detection of Experimental Method of Warfarin Medication Guidance Project

[0020] Step 1: Extract DNA

[0021] Transfer the oral swab sample to a 1.5ml EP tube, add 100μl Lysis Solution, mix well, heat at 95°C for 3min, take it out and place it at room temperature, when the temperature drops to room temperature, add 100μl DNA Stabilizing Solution, mix well, and place it at 4°C save.

[0022] Reagents used: DNA Extract All Reagents (ABI)

[0023] Step 2: Prepare reagents

[0024] reaction system:

[0025]

[0026] Among them, the concentration of both the forward and reverse primers was 10 μmol / L, and the concentration of the probe was 20 μmol / L.

[0027] Step 3: Point board

[0028] According to the above reaction system, add samples to the plate, 10 μl per well. After adding, seal the membrane, centrifuge, and remove air bubbles.

[0029] Consumables and instruments used: MicroAMP Optical 384-Well Reaction Plate with Barcode; Micr...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention belongs to the technical field of biology and relates to a primer-probe combination and a kit for detecting associated genotyping of warfarin medication. The invention provides primers and probes for detecting associated genotyping of warfarin medication. The sequences of the primers are shown as SEQ ID NO.1-SEQ ID NO.6, and the sequences of the probes are shown as SEQ ID NO.7-SEQ ID NO.12. The primer-probe combination and the kit for detecting associated genotyping of warfarin medication have the advantages that development and application of the gene detection kit are guided through warfarin medication, typing of the three genes of CYP2C9*3, CYP4F2 and VKORC1 is facilitated and easily achieved, and noninvasive diagnosis is guaranteed to enable clinicians to master patient heredity conditions rapidly and accurately, decrease medical accident incidence caused by inappropriate medicine dose greatly, reduce medication side effect and lay the foundation for improvement on clinical treatment effect; since only about 2 hours is needed for detection of every sample, high detection speed is achieved.

Description

technical field [0001] The invention belongs to the field of biotechnology, and relates to a combination of primers and probes and a kit for warfarin medication guiding gene detection. Background technique [0002] Warfarin is a drug commonly used in clinical practice for the prevention and treatment of thromboembolic diseases. It is a kind of coumarin anticoagulant and has an anti-vitamin K effect in the body. Warfarin can inhibit the synthesis of blood coagulation factors Ⅱ, Ⅶ, Ⅸ, and Ⅹ involved in vitamin K in the liver, and the effect and maintenance time are longer after the onset of effect. It is mainly used to prevent and treat thromboembolic diseases. The dose-response (international normalized ratio) relationship of warfarin is highly variable and influenced by many factors, and overdose can lead to bleeding, so close monitoring is required. [0003] The dose-effect relationship of warfarin is affected by genetic and environmental factors. Genetic factors mainly ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): C12Q1/6883C12N15/11
CPCC12Q1/6883C12Q2600/106C12Q2600/156
Inventor 李小龙
Owner CHANGZHOU TCM HOSPITAL
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products